The round was led by CVS Health Ventures, with participation from existing investors LiveOak Ventures and Dallas Venture Partners. This investment will accelerate AmplifAI's mission to unify human and AI agent performance and deliver best-in-class customer experience at scale.

AmplifAI is an AI-powered platform for contact center performance analytics that helps organizations optimize their workforce by ensuring agents focus on complex, high-value interactions while AI seamlessly manages simpler contacts. By transforming raw interaction data into actionable insights, AmplifAI enables enterprises to enhance customer experience, increase agent effectiveness, improve AI Agent performance and drive operational efficiency.